Education
About Us
Working with TipRanks
Follow Us
Jacobson Pharma Corporation Limited (HK:2633)
:2633
RESEARCH TOOLSreports
Total Valuation
Jacobson Pharma Corporation Limited has a market cap or net worth of HK$2.70B. The enterprise value is HK$2.42B.
Market CapHK$2.70B
Enterprise ValueHK$2.42B
Share Statistics
Jacobson Pharma Corporation Limited has 2,000,221,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding2,000,221,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Jacobson Pharma Corporation Limited’s return on equity (ROE) is 0.11 and return on invested capital (ROIC) is 8.45%.
Return on Equity (ROE)0.11
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)8.45%
Return on Capital Employed (ROCE)0.11
Revenue Per Employee848.44K
Profits Per Employee184.41K
Employee Count1,730
Asset Turnover0.42
Inventory Turnover2.67
Valuation Ratios
The current PE Ratio of Jacobson Pharma Corporation Limited is 4.17. Jacobson Pharma Corporation Limited’s PEG ratio is 0.18.
PE Ratio4.17
PS Ratio0.00
PB Ratio0.68
Price to Fair Value0.47
Price to FCF3.17
Price to Operating Cash Flow2.86
PEG Ratio0.18
Income Statement
In the last 12 months, Jacobson Pharma Corporation Limited had revenue of 1.47B and earned 266.97M in profits. Earnings per share was 0.07.
Revenue1.47B
Gross Profit620.48M
Operating Income333.13M
Pretax Income254.58M
Net Income266.97M
EBITDA489.81M
Earnings Per Share (EPS)0.07
Cash Flow
In the last 12 months, operating cash flow was 495.44M and capital expenditures -65.47M, giving a free cash flow of 429.97M billion.
Operating Cash Flow495.44M
Free Cash Flow429.97M
Free Cash Flow per Share0.21
Dividends & Yields
Jacobson Pharma Corporation Limited pays an annual dividend of HK$0.059, resulting in a dividend yield of 4.93%
Dividend Per ShareHK$0.059
Dividend Yield4.93%
Payout Ratio13.88%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.27
52-Week Price Change149.12%
50-Day Moving Average1.25
200-Day Moving Average0.96
Relative Strength Index (RSI)70.82
Average Volume (3m)1.01M
Important Dates
Jacobson Pharma Corporation Limited upcoming earnings date is Nov 21, 2025, TBA Not Confirmed.
Last Earnings DateJun 13, 2025
Next Earnings DateNov 21, 2025
Ex-Dividend DateAug 11, 2025
Financial Position
Jacobson Pharma Corporation Limited as a current ratio of 2.59, with Debt / Equity ratio of 58.43%
Current Ratio2.59
Quick Ratio1.73
Debt to Market Cap0.63
Net Debt to EBITDA0.69
Interest Coverage Ratio4.23
Taxes
In the past 12 months, Jacobson Pharma Corporation Limited has paid 44.41M in taxes.
Income Tax44.41M
Effective Tax Rate0.17
Enterprise Valuation
Jacobson Pharma Corporation Limited EV to EBITDA ratio is 2.96, with an EV/FCF ratio of 4.09.
EV to Sales0.99
EV to EBITDA2.96
EV to Free Cash Flow4.09
EV to Operating Cash Flow3.00
Balance Sheet
Jacobson Pharma Corporation Limited has HK$563.79M in cash and marketable securities with HK$699.85M in debt, giving a net cash position of HK$136.06M billion.
Cash & Marketable SecuritiesHK$563.79M
Total DebtHK$699.85M
Net CashHK$136.06M
Net Cash Per ShareHK$0.07
Tangible Book Value Per ShareHK$1.02
Margins
Gross margin is 41.84%, with operating margin of 22.70%, and net profit margin of 18.19%.
Gross Margin41.84%
Operating Margin22.70%
Pretax Margin17.34%
Net Profit Margin18.19%
EBITDA Margin33.37%
EBIT Margin22.71%
Analyst Forecast
The average price target for Jacobson Pharma Corporation Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-7.15%
EPS Growth Forecast2.38%